Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome)

Nephrology Dialysis Transplantation

Volumn 15, Issue 7, 2000, Pages 953-960

  Stenvinkel, Peter ^a   Heimbürger, Olof ^a   Lindholm, Bengt ^a   Kaysen, George A ^b,c   Bergström, Jonas ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; CYTOKINE; NITRIC OXIDE; THALIDOMIDE;

ANTHROPOMETRY; ATHEROGENESIS; ATHEROSCLEROSIS; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; ENERGY EXPENDITURE; FOOD INTAKE; HAND GRIP; HEMODIALYSIS; HUMAN; HYPOALBUMINEMIA; INFLAMMATION; MALNUTRITION; NAUSEA; NOTE; NUTRITION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INTAKE; VASCULAR ENDOTHELIUM; VOMITING; WASTING SYNDROME;

EID: 0342588054     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.7.953     Document Type: Note

References (96)

1. Marckmann P. Nutritional status of patients on hemodialysis and peritoneal dialysis. Clin Nephrol 1988; 29: 75-78
2. Bergström J, Lindholm B. Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare? Kidney Int 1993; 34: S39
3. Cianciaruso B, Brunori G, Kopple JD et al. Cross-sectional comparison of malnutrition in continuous ambulatory dialysis and hemodialysis patients. Am J Kidney Dis 1995; 26: 475-483
4. Qureshi AR, Alvestrand A, Danielsson A, Divino-Filho JC, Gutierrez A, Lindholm B et al. Factors influencing malnutrition in hemodialysis patients. A cross-sectional study. Kidney Int 1998; 53: 773-782
5. Simons JP, Scols AM, Buurman WA, Wouters EF. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci 1999; 97: 215-223
6. Munro R, Capell H. Prevalence of low body mass in rheumatoid arthritis: associations with the acute phase response. Ann Rheum Dis 1997; 56: 326-329
7. Stenvinkel P, Heimbürger O, Paultre F et al. Strong associations between malnutrition, inflammation and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911
8. Heimbürger O, Qureshi AR, Blaner WS, Berglund L, Stenvinkel P. Hand-grip muscle strength, lean body mass and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. Am J Kidney Dis 2000; in press
9. Johanson A, Samuelsson O, Haraldson B, Bosaeus J, Attman P-O. Body composition in patients treated with peritoneal dialysis. Nephrol Dial Transplant 1998; 13: 1511-1517
10. Hakim RM, Levin N. Malnutrition in hemodialysis patients. Am J Kidney Dis 1993; 21: 125-137
11. Kopple JD. Dietary protein and energy requirements in ESRD patients. Am J Kidney Dis 1998; 32[Suppl. 4]: S97-S104
12. Monteon FJ, Laidlaw SA, Shaib JK, Kopple JD. Energy expenditure in patients with chronic renal failure. Kidney Int 1986; 30: 741-747
13. Schneeweiss B, Graninger W, Stockenhuher F et al. Energy metabolism in acute and chronic renal failure. Am J Clin Nutr 1990; 52: 596-601
14. Ikizler TA, Wingard RL, Sun M, Harvell J, Parker RA, Hakim RM. Increased energy expenditure in hemodialysis patients. J Am Soc Nephrol 1996; 7: 2646-2653
15. Bergström J, Fürst P, Alvestrand A, Lindholm B. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 1993; 44: 1048-1057
16. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-482
17. Avram MM, Fein PA, Bonomini L et al. Predictors of survival in continuous ambulatory peritoneal dialysis patients: a five year prospective study. Peritoneal Dial Int 1996; 16 [Suppl. 1]: S190-S194
18. Avram MM, Goldwasser P, Erroa M, Fein PA. Predictors of survival in continuous ambulatory peritoneal dialysis patients: the importance of prealbumin and other nutritional and metabolic parameters. Am J Kidney Dis 1994; 23: 91-98
19. Folsom AR, Ma J, Eckfeldt JH, Nieto FJ, Metcalfe PA, Barnes RW. Low serum albumin. Association with diabetes mellitus and other cardiovascular risk factors but not with prevalent cardiovascular disease or carotid artery intima media-media thickness. Ann Epidemiol 1995; 5: 186-191
20. Koch M, Kutkuhn B, Grabensee B, Ritz E. Apolipoprotein A, fibrinogen, age, and a history of stroke are predictors of death in dialyzed diabetic patients: a prospective study in 412 subjects. Nephrol Dial Transplant 1997; 12: 2603-2611
21. Struijk DG, Krediet RT, Koomen GCM, Boeschoten EW, Arisz L. The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival. Peritoneal Dial Int 1994; 14: 121-126
22. Acchiardo SR, Moore LW, Latour PA. Malnutrition as a main factor in morbidity and mortality of hemodialysis patients. Kidney Int 1983; 24 [Suppl. 16]: S199-S203
23. Kaysen GA. Biological basis of hypoalbuminemia in ESRD. Kidney Int 1998; 9: 2368-2376
24. Smith G, Robinson PH, Fleck A. Serum albumin distribution in early treated anorexia nervosa. Nutrition 1996; 12: 677-684
25. Keys A, Brozek J, Henschel A, Mickelsen O, Taylor HL. The biology of human starvation. The University of Minnesota Press, Minneapolis, 1950
26. Schoenfeld PY. Albumin is an unreliable marker of nutritional status. Semin Dial 1992; 5: 218-223
27. Heimbürger O, Bergström J, Lindholm B. Is serum albumin an indication of nutritional status in CAPD patients? Peritoneal Dial Int 1994; 14: 108-114
28. Kaysen GA, Schonfeld PY. Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 1984; 25: 107-114
29. Kaplan AA, Halley SE, Lapkin RA, Graeber CW. Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int 1995; 47: 573-578
30. Moshage HJ, Janssen JAM, Franssen JH, Hafkenscheid JCM, Yap SH. Study of the molecular mechanisms of decreased liver synthesis of albumin in inflammation. J Clin Invest 1987; 79: 1635-1641
31. Kaysen GA, Stevenson FT, Depner TA. Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 1997; 29: 658-668
32. Yeun JY, Kaysen GA. Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin and peritoneal dialysis patients. Am J Kidney Dis 1997; 30: 923-927
33. Bergström J, Heimbürger O, Lindholm B, Qureshi AR. Elevated serum C-reactive protein is a strong predictor of increased mortality and low serum albumin in hemodialysis (HD) patients. J Am Soc Nephrol 1995; 6: 573
34. Bologa RM, Levine DM, Parker TS et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 1998; 32: 107-114
35. Ridker PM, Cushman M, Stampfer MJ, Russell PT, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979
36. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR. C-reactive protein and outcome after ischemic stroke. Stroke 1999; 30: 981-985
37. Harris TB, Ferrucci L, Tracy RP et al. Association of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999; 106: 506-512
38. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-658
39. Iseki K, Tozawa M, Yoshi S, Fukiyama K. Serum C-reactive (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 1999; 14: 1956-1960
40. Ikizler TA, Wingard RL, Harvell J, Shyr Y, Hakim RM. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study. Kidney Int 1999; 55: 1945-1951
41. Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 1998; 54: 627-636
42. Pereira BJG, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA. Plasma levels of IL-1β, TNF-α and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 1994; 45: 890-896
43. Kimmel PL, Phillips TM, Simmens SJ et al. Immunologic function and survival in hemodialysis patients. Kidney Int 1998; 54: 236-244
44. Bistrian BR, Schwartz J, Istfan NW. Cytokines, muscle proteolysis, and the catabolic response to infection and inflammation. Proc Soc Exp Biol Med 1992; 200: 220-223
45. Plata-Salamán CR. Cytokines and anorexia: a brief overview. Semin Oncol 1998; 25: 64-72
46. Nawabi MD, Block KP, Chakrabarti MC, Buse MG. Administration of endotoxin, tumour necrosis factor, or interleukin-1 to rats activates skeletal muscle branched-chain alpha-keto acid dehydrogenase. J Clin Invest 1990; 85: 256-263
47. Schneeweiss B, Druml W, Graninger W et al. Energy metabolism in patients with severe heart failure. Wien Klin Wochenschr 1987; 99: 710-712
48. Falconer JS, Fearon KCH, Plesler CE, Ross JA, Carter DC. Cytokines, the resting acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg 1994; 219: 325-331
49. Staal-van den Brekel AJ, Dentener MA, Schols AM, Buurman WA, Wouters EF. Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol 1995; 13: 2600-2605
50. Roubenhoff R, Roubenhoff RA, Cannon JG et al. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 1994; 93: 2379-2386
51. Heijligenberg R, Romijn JA, Westerterp KR, Jonkers CF, Prins JM, Sauerwein HP. Total energy expenditure in human immunodeficiency virus-infected men and healthy controls. Metab Clin Exp 1997; 46: 1324-1326
52. Harty J, Conway L, Keegan M et al. Energy metabolism during CAPD; a controlled study. Adv Peritoneal Dial 1995; 11: 229-233
53. Campillo B, Bories PN, Devanlay M et al. Aging, energy expenditure and nutritional status: evidence for denutrition-related hypermetabolism. Ann Nutr Metab 1992; 36: 265-272
54. Maggi E, Bellazzi R, Falaschi F et al. Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis. Kidney Int 1994; 45: 876-883
55. Stenvinkel P, Holmberg I, Heimbürger O, Diczfalusy U. A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients. Nephrol Dial Transplant 1998; 13: 2594-2600
56. Sguyen-Choa T, Massy ZA, DeBandt JP et al. Factors influencing oxidative stress in hemodialysis (HD) patients. J Am Soc Nephrol 1999; 10: 296
57. Witko-Sarsat V, Friedlander M, Khoa TN et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998; 161: 2524-2532
58. Cha MK, Kim IH. Glutahthione-linked thiol peroxidase activity of human serum albumin: a possible antioxidant role of serum albumin in blood plasma. Biochem Biophys Res Commun 1996; 222: 619-625
59. Soejima A, Matsuzawa N, Miyake N et al. Hypoalbuminemia accelerates erythrocyte membrane lipid peroxidation in chronic hemodialysis patients. Clin Nephrol 1999; 51: 92-97
60. Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocysteinemia in humans. Circulation 1999; 100: 1161-1168
61. Werver R, Boer P, Hijmering M et al. Nitric oxide production is reduced in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 1999; 19: 1168-1172
62. Matsumoto A, Hirata Y, Kakoki M et al. Increased excretion of nitric oxide in exhaled air of patients with chronic renal failure. Clin Sci 1999; 96: 67-74
63. van Guldener C, Janssen MJ, Lambert J, Steyn M, Donker AJ, Steuhower CC. Endothelium-dependent vasodilation is impaired in peritoneal dialysis patients. Nephrol Dial Transplant 1998; 13: 1782-1786
64. Hand MF, Haynes WG, Webb DJ. Hemodialysis and L-arginine, but not D-arginine, correct renal-failure associated endothelial dysfunction. Kidney Int 1998; 53: 1068-1077
65. Keaney JF, Simon DI, Stamler JS et al. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest 1993; 91: 1582-1589
66. Kim SB, Chi HS, Park JS, Hong CD, Yang WS. Effect of increasing serum albumin on plasma D-dimer, von Willebrand factor, and platelet aggregation in CAPD patients. Am J Kidney Dis 1999; 33: 312-317
67. Kessler P, Popp R, Busse R, Schini-Kerth VB. Proinflammatory mediators chronically downregulate the formation of the endothelium-derived hyperpolarizing factor in arteries via a nitric oxide/cyclic GMP-dependent mechanism. Circulation 1999; 99: 1878-1884
68. Schalkwijk CG, Poland DC, van Dijk W et al. Plasma concentrations of C-reactive protein is increased in type 1 diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia 1999; 42: 351-357
69. Carr JG, Stevensson LW, Walden JA, Heber D. Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1989; 63: 709-713
70. Mancini DM, Walter G, Reicek N et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992; 85: 1364-1373
71. Volterrani M, Clark AL, Ludman PF et al. Determinants of exercise capacity in chronic heart failure. Eur Heart J 1994; 15: 801-809
72. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-241
73. Munger MA, Johnsson B, Amber IJ, Callahan KS, Bilbert EM. Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1996; 77: 723-727
74. Anker SD, Ponikowski P, Varney S et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997; 349: 1050-1053
75. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 1996; 11:1277-1285
76. Bergström J, Lindholm B. Malnutrition, cardiac disease and mortality - an integrated point of view. Am J Kidney Dis 1998; 32: 834-841
77. EDTA/ERA Registry Report. Demography of dialysis and transplantation in Europe 1984. Nephrol Dial Transplant 1986; 1: 1-8
78. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal failure. Am J Kidney Dis 1998; 32 [Suppl. 5]: S112-S119
79. Stenvinkel P, Heimbürger O, Wang T, Elinder C-G, Bergström J, Lindholm B. A syndrome of malnutrition, inflammation and atherosclerosis (MIA) is associated with elevated serum hyaluronan and increased mortality in chronic renal failure (CRF). J Am Soc Nephrol 1999; 10: 182A
80. Keane WF, Collins AJ. Influence of co-morbidity on mortality and morbidity of hemodialysis patients. Am J Kidney Dis 1994; 24:1010-1018
81. Baltzan MA, Shoker AS. Malnutrition and dialysis (letter). Kidney Int 1998; 53: 999
82. Kopple JD, Chumlea WC, Gassman JJ, et al. Relationship between GFR and nutritional status - results from the MDRD study. J Am Soc Nephrol 1994; 5: 335
83. Ikizler TA, Greene JH, Wingard RL, Parker RA, Hakim RM. Spontaneous dietary intake during progression of chronic renal failure. Kidney Int 1995; 6: 1386-1391
84. Foulks CJ. An evidence-based evaluation of intradialytic parenteral nutrition. Am J Kidney Dis 1999; 33: 186-192
85. Davies SJ, Phillips L, Griffiths AM, Naish PF, Russell GI. An analysis of the effects of increasing delivered dialysis treatment to malnourished peritoneal dialysis patients. Kidney Int 2000; 57: 1743-1754
86. Ericsson F, Divino JD, Lindgren B. Low grade inflammatory activity abolishes the anabolic effect of growth hormone (GH) on metabolism in hemodialysis patients. J Am Soc Nephrol 1999; 10: 162A
87. Beddhu S, Zeidel S, Stark S, Saul M, Bruns F. Comorbidity influences the impact of albumin (Alb) on dialysis outcomes. J Am Soc Nephrol 1999; 10: 234A
88. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685-691
89. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the north Scandinavian enalapril survival study. N Engl J Med 1987; 316: 1429-1435
90. Stenvinkel P, Andersson P, Wang T et al. Do ACE-inhibitors suppress tumor necrosis factor-α production in advanced chronic renal failure? J Intern Med 1999; 246: 503-507
91. Anker SD, Negassa A, Coats AJ, Poole-Wilson PA, Yusuf S. Weight loss in chronic heart failure (CHF) and the impact of treatment with ACE inhibitors. Results from the SOLVD treatment trial. Circulation 1999; 100: 1781
92. Solzbach U, Hornig B, Jeserich M, Just H. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients. Circulation 1997; 96: 1513-1519
93. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350: 430-436
94. Elliot MJ, Maini RN, Feldmann M et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 1994; 344: 1105-1110
95. Reyes-Terán G, Sierra-Madero JG, Martínez del Cerro V et al. Effects of thalidomide on HIV-associated wasting syndrome: a randomized, double blind, placebo-controlled clinical study. AIDS 1996; 10: 1501-1507
96. Tramontana JM, Utaipat U, Molloy A, Akarasewi P, Burroughs M, Makonkawkeyoon S et al. Thalidomide treatment reduces tumour necrosis factor-α production and enhances weight gain in patients with pulmonary tuberculosis. Mol Med 1995; 1: 384-397